Insider Transactions in Q4 2024 at Natera, Inc. (NTRA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
81
-0.07%
|
-
|
|
Dec 19
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
125
-0.11%
|
-
|
|
Dec 18
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
2,148
-0.91%
|
$358,716
$167.09 P/Share
|
|
Dec 18
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
852
-1.79%
|
$142,284
$167.07 P/Share
|
|
Dec 18
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.35%
|
$450,900
$167.12 P/Share
|
|
Dec 13
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
160,000
-1.28%
|
$26,560,000
$166.45 P/Share
|
|
Dec 10
2024
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct |
1,767
-22.17%
|
$300,390
$170.24 P/Share
|
|
Dec 09
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
4,858
-4.06%
|
$806,428
$166.59 P/Share
|
|
Dec 09
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Grant, award, or other acquisition
|
Direct |
9,075
+3.7%
|
$90,750
$10.15 P/Share
|
|
Dec 05
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Exercise of conversion of derivative security
|
Direct |
68,496
+2.62%
|
$342,480
$5.4 P/Share
|
|
Dec 02
2024
|
Roelof Botha Director |
SELL
Open market or private sale
|
Indirect |
87,473
-1.37%
|
$14,695,464
$168.7 P/Share
|
|
Nov 26
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
2,000
-0.78%
|
$328,000
$164.35 P/Share
|
|
Nov 25
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
2,000
-0.76%
|
$336,000
$168.91 P/Share
|
|
Nov 19
2024
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
9,682
-28.45%
|
$1,549,120
$160.18 P/Share
|
|
Nov 15
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,628
-0.49%
|
$680,316
$147.3 P/Share
|
|
Nov 15
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$14,600
$146.35 P/Share
|
|
Nov 15
2024
|
Roy D. Baynes |
SELL
Open market or private sale
|
Direct |
37,230
-17.42%
|
$5,435,580
$146.96 P/Share
|
|
Nov 15
2024
|
Roy D. Baynes |
BUY
Exercise of conversion of derivative security
|
Direct |
37,230
+29.55%
|
$856,290
$23.63 P/Share
|
|
Nov 14
2024
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
2,212
-2.13%
|
$351,708
$159.14 P/Share
|
|
Nov 13
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
16,300
-5.06%
|
$2,526,500
$155.61 P/Share
|
|
Nov 13
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
20,000
-3.64%
|
$3,060,000
$153.4 P/Share
|
|
Nov 12
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.4%
|
$50,000
$5.4 P/Share
|
|
Nov 11
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+5.0%
|
$650,000
$5.4 P/Share
|
|
Nov 08
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-1.05%
|
$393,000
$131.02 P/Share
|
|
Nov 08
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.32%
|
$351,000
$130.84 P/Share
|
|
Oct 31
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,866
-2.64%
|
$235,116
$126.45 P/Share
|
|
Oct 29
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
754
-1.06%
|
$89,726
$119.93 P/Share
|
|
Oct 28
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,238
-1.7%
|
$146,084
$118.21 P/Share
|
|
Oct 28
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,960
-2.04%
|
$467,280
$118.21 P/Share
|
|
Oct 28
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
929
-0.81%
|
$109,622
$118.21 P/Share
|
|
Oct 28
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,196
-1.07%
|
$141,128
$118.21 P/Share
|
|
Oct 28
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,057
-0.51%
|
$124,726
$118.21 P/Share
|
|
Oct 25
2024
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
124
+0.78%
|
-
|
|
Oct 25
2024
|
Roelof Botha Director |
BUY
Grant, award, or other acquisition
|
Direct |
203
+5.11%
|
-
|
|
Oct 25
2024
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
153
+0.33%
|
-
|
|
Oct 25
2024
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
178
+0.27%
|
-
|
|
Oct 25
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
691
-0.94%
|
$81,538
$118.81 P/Share
|
|
Oct 24
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
914
-1.23%
|
$108,766
$119.19 P/Share
|
|
Oct 23
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
496
-0.66%
|
$59,024
$119.09 P/Share
|
|
Oct 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.64%
|
-
|
|
Oct 22
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
199
-0.17%
|
$23,880
$120.07 P/Share
|
|
Oct 22
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
256
-0.23%
|
$30,720
$120.07 P/Share
|
|
Oct 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
454
-0.61%
|
$54,480
$120.07 P/Share
|
|
Oct 22
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
893
-0.46%
|
$107,160
$120.07 P/Share
|
|
Oct 22
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
349
-0.17%
|
$41,880
$120.07 P/Share
|
|
Oct 21
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
342
-0.3%
|
$41,040
$120.76 P/Share
|
|
Oct 21
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
294
-0.26%
|
$35,280
$120.76 P/Share
|
|
Oct 21
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
608
-0.81%
|
$72,960
$120.76 P/Share
|
|
Oct 21
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+1.51%
|
-
|
|
Oct 21
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,709
-0.87%
|
$205,080
$120.76 P/Share
|